Tag Archives: treatment

New online tool is set to revolutionize blood pressure treatment

New online tool is set to revolutionize blood pressure treatment

High blood pressure is the number one reason that most people visit their doctor. Known as the “silent assassin,” it often creeps in quietly. You feel fine, yet the force in your arteries runs high day after day. The top number, called systolic pressure, is the one doctors watch most closely because it signals how hard your heart is working …

Read More »

LASIK alternative? Early test of new laser-free eye treatment shows promise

LASIK alternative? Early test of new laser-free eye treatment shows promise

Scientists have developed a potential new method for corrective eye surgery that doesn’t use lasers, but instead shapes the eye’s outer surface using an electrical current. The method has so far been tested only in animals, but the researchers who pioneered it hope that it will someday offer an alternative or complement to conventional LASIK surgery. The team presented their …

Read More »

Getting gum disease treatment may protect your arteries, study finds

Getting gum disease treatment may protect your arteries, study finds

Research has long pointed to a link between poor gum health and a higher risk of cardiovascular disease — and now, a new trial suggests that treating severe gum disease may reduce the narrowing of a major artery over time in otherwise healthy people. Likely by reducing inflammation, this routine oral hygiene procedure may be an unsung way of minimizing …

Read More »

UC Davis Medical Center to become special pathogen treatment center

UC Davis Medical Center to become special pathogen treatment center

UC Davis Medical Center will soon become the first special pathogen treatment center in Northern California. The new classification, known as National Special Pathogens System (NSPS) Level 2, means the hospital will be able to treat patients infected with contagious infectious diseases like Ebola and the Marburg virus. UC Davis said the new classification is thanks to $1.2 million in …

Read More »

First-Ever Treatment for Rare Eye Disease Wins FDA Approval After Landmark Trials

First-Ever Treatment for Rare Eye Disease Wins FDA Approval After Landmark Trials

A novel implant has shown it can slow vision loss in macular telangiectasia type 2, offering the first approved treatment for this rare disorder. Credit: Stock Phase 3 clinical trial results from Scripps Research and its collaborators supported FDA approval of ENCELTO, the first cell-based treatment for the neurodegenerative retinal disease known as MacTel. For individuals with macular telangiectasia type …

Read More »

Lilly's oral GLP-1, orforglipron, is successful in third Phase 3 trial, triggering global regulatory submissions this year for the treatment of obesity – Eli Lilly and Company

Lilly’s oral GLP-1, orforglipron, is successful in third Phase 3 trial, triggering global regulatory submissions this year for the treatment of obesity  Eli Lilly and Company Eli Lilly’s weight loss pill orforglipron clears its latest trial, paving way for approval  CNBC Eli Lilly Ready to Seek Obesity Pill Green Light After Study Hits Goals  The Wall Street Journal Eli Lilly’s weight-loss pill meets …

Read More »

Pea Plant Virus Creates a Powerful Immune Attack on Cancer—A Cheap Treatment Headed for Clinical Trials

Pea Plant Virus Creates a Powerful Immune Attack on Cancer—A Cheap Treatment Headed for Clinical Trials

Immunotherapy vaccine attacks cancer cells A virus that infects the humble black-eyed pea plant is showing great promise as a low-cost, potent cancer immunotherapy—thanks to researchers at the University of California San Diego. The team led by chemical and nano engineers just published their study in Cell Biomaterials, showing how the cowpea mosaic virus (CPMV), unlike other plant viruses, is …

Read More »

DAWNZERA (donidalorsen) approved in the U.S. as first and only RNA-targeted prophylactic treatment for hereditary angioedema – Business Wire

DAWNZERA (donidalorsen) approved in the U.S. as first and only RNA-targeted prophylactic treatment for hereditary angioedema  Business Wire US FDA approves Ionis’ drug for rare genetic disorder  Reuters FDA approves Ionis drug that prevents swelling attacks caused by a rare disease  statnews.com FDA clears Ionis’ Dawnzera as first RNA-targeting preventative shot for HAE  FirstWord Pharma FDA approves Ionis’ hereditary angioedema drug  BioPharma Dive Source link

Read More »